Article Text

PDF

O034 Whole genome sequencing to predict Neisseria gonorrhoeae antibiotic susceptibility: toward tailored antimicrobial therapy
  1. Laura Phillips1,
  2. Adam Witney1,
  3. Ken Laing1,
  4. Kate Gould1,
  5. Marcus Pond1,
  6. Catherine Hall1,
  7. Emma Harding-Esch1,2,
  8. Philip Butcher1,
  9. S Tariq Sadiq1
  1. 1St George’s University of London, London, UK
  2. 2Public Health England, London, UK

Abstract

Background/introduction Absence of genotypic resistance-associated markers in Neisseria gonorrhoeae (NG) may predict antibiotic phenotypic susceptibility (APS). NG Whole genome sequencing (NG-WGS) on nucleic acid amplification test (NAAT) positive samples may allow for the avoidance and preservation of first line treatments such as ceftriaxone. However, NG-WGS predictive accuracy for APS should first be established.

Aim(s)/objectives To evaluate NG-WGS “wild-type” predictive value for tetracycline, ciprofloxacin and azithromycin APS.

Methods NG-WGS was performed on prospectively collected NG isolates from a London clinic in 2013, using Illumina MiSeq. Presence of 31 known single nucleotide polymorphisms (SNPs) and other resistance markers for tetracycline, ciprofloxacin, and azithromycin, were compared against a wild-type reference NG strain (FA1090).

Results Of 57 samples, APS to tetracycline, ciprofloxacin, and azithromycin was 14%, 72% and 87% respectively. Genotypic susceptibility (GeSu) was defined as absence of SNPs and other resistance-associated markers. For tetracyclines, ciprofloxacin and azithromycin, GeSu-Tet, GeSu-Cip and GeSu-Azi, accurately predicted APS in 7/8 (87.5%; 95% CI 52.9%–97.8%), 40/41 (97.6%; 95% CI 87.4%–99.6%) and 25/25 (100%; 95% CI 86.7%–100%) respectively. One phenotypically resistant GeSu-Tet isolate had “Intermediate” resistance. Of seven isolates, both genotypically and phenotypically susceptible to tetracyclines, all were also susceptible to ciprofloxacin, 24/25 isolates susceptible to azithromycin were also susceptible to ciprofloxacin.

Discussion/conclusion NG-WGS accurately predicted ciprofloxacin and azithromycin but not tetracycline APS. If validated on NG NAAT positive samples, this may allow for new precision ceftriaxone-sparing or ceftriaxone-adjunctive treatment combinations, for a substantial proportion of patients.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.